Replies to post #535280 on NorthWest Biotherapeutics Inc (NWBO)

[hope4patients]

DCVAX technology = all solid tumor cancers (both operable and inoperable). The market is enormous.

[SkyLimit2022]

I am not qualified to say anything accurate about dollar amounts, but based my research, NWBO surpasses most or all recent acquisitions in value based on the fact that murcidencel is a cell-based platform.

The value seems to be double-digit billions for the unmet need of rGBM alone. Then, you might wish to factor in nGBM and other cancers. Furthermore, you might wish to factor in its value in combo with other technologies.

For me, its minimum value is huge and its full potential is immeasurable. I am just an individual investor and will be quite happy with any number within its likely range of value.

Its true value to humanity cannot be measured in dollars.

https://nwbio.com/wp-content/uploads/jamaoncology_liau_2022_oi_220066_1668698380.80695.pdf

[Horseb4CarT]

Celgene was bought by BMY after Celgene had big revenues from Revlimid and early investors had something like 5000% returns already.

I bought Celgene stock fairly late and still made 2-3 times my investment (a much, much smaller investment than for nwbo) however nwbo is very different, being pre-revenue and about to apply for its first approval, no substantial corporate functional/staff structure, no marketing/sales, No PAC, etc.

So nwbo is more like Celgene in its infancy.

Imo nwbo has a much larger potential to grow into than Celgene in due time.

It’s also imo and self interests that me being decades older than when I bought Celgene, as are LP and LG, that making a fair deal with an entity that will be committed to make the most of the technology for humanity and not shelve it, is preferred for investors like me and cancer patients worldwide!